Immunoglobulin use and outcomes in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma - The ICAN Study

Not Applicable

Completed

• Conditions: Chronic Lymphocytic Leukaemia; Non-Hodgkin's Lymphoma; Cancer - Leukaemia - Chronic leukaemia; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma; Cancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma

• Registration Number: ACTRN12619001201167
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-27
• Study Completion: 2022-07-31
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 576

Inclusion Criteria

Newly diagnosed with CLL or B-cell NHL
A participant in the LaRDR

Exclusion Criteria

Patients who decline to participate
For Biobank participants: Patients who have commenced treatment

Study & Design

• Study Type: Observational
• Study Design: Not specified